🔥🐔 BizChicken 🐔🔥
Companies Similar to Protagonist Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Fulcrum Therapeutics, Inc.
losmapimod and FTX-6058
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing products to improve the lives of patients with genetically defined diseases in areas of high unmet medical need in the United States.
Symbol: FULC
Recent Price: $4.68
Industry: Biotechnology
CEO: Mr. Alexander C. Sapir
Sector: Healthcare
Employees: 76
Address: 26 Landsdowne Street, Cambridge, MA 02139
Phone: 617 651 8851
Last updated: 2024-12-31
Prelude Therapeutics Incorporated
PRT543
Prelude Therapeutics Incorporated is a clinical-stage precision oncology company focusing on novel precision cancer medicines, including products like PRT543, PRT811, PRT1419, PRT2527, and others at various stages of development or trials.
About | Leadership | Directors | About | Contact | Contact | Careers | Careers | Jobs | About | About
Symbol: PRLD
Recent Price: $1.21
Industry: Biotechnology
CEO: Dr. Krishna Vaddi D.V.M., Ph.D.
Sector: Healthcare
Employees: 128
Address: 200 Powder Mill Road, Wilmington, DE 19803
Phone: 302 467 1280
Leadership
- Kris Vaddi, Ph.D., Chief Executive Officer
- Jane Huang, M.D., President and Chief Medical Officer
- Bryant Lim, Chief Legal Officer, Corporate Secretary & Interim Chief Financial Officer
- Andrew Combs, Ph.D., Chief Chemistry Officer
- Peggy Scherle, Ph.D., Chief Scientific Officer
- Michele Porreca, M.B.A., Chief People Officer
- Sean Brusky, M.B.A., Chief Business Officer
- Naveen Babbar, Ph.D., Senior Vice President, Translation Medicine
- Aimee Crombie, Ph.D., SVP & Head of Strategic Planning & Operations
- Robert Doody, Senior Vice President, Investor Relations
- Wan-Jen Hong, M.D., Senior Vice President, Clinical Development
- Bill Novotny, M.D., Senior Vice President, Clinical Development
- Madhu Pudipeddi, Ph.D., Senior Vice President, Technical Operations
- Paul A. Friedman, M.D., Chair
- David Bonita, M.D., Director
- Julian C. Baker, Director
- Mardi C. Dier, Director
- Victor Sandor, M.D., Director
- Martin Babler, Director
Last updated: 2024-12-31
Protagonist Therapeutics, Inc.
rusfertide (PTG-300), PN-943, PN-235
Protagonist Therapeutics, Inc. is a biopharmaceutical company that focuses on the discovery and development of peptide-based therapeutic drugs for hematology, blood disorders, and inflammatory and immunomodulatory diseases.
Symbol: PTGX
Recent Price: $38.51
Industry: Biotechnology
CEO: Dr. Dinesh V. Patel Ph.D.
Sector: Healthcare
Employees: 125
Address: 7707 Gateway Boulevard, Newark, CA 94560-1160
Phone: 510 474 0170
Last updated: 2024-12-31
Altimmune, Inc.
Pemvidutide
Altimmune, Inc. focuses on developing treatments for obesity and liver diseases with lead product candidate pemvidutide, and Hep Tcell in clinical trials.
Symbol: ALT
Recent Price: $7.32
Industry: Biotechnology
CEO: Dr. Vipin K. Garg Ph.D.
Sector: Healthcare
Employees: 59
Address: 910 Clopper Road, Gaithersburg, MD 20878
Phone: 240 654 1450
Last updated: 2024-12-31
Apogee Therapeutics, Inc.
APG777, APG808, APG990, APG222
Apogee Therapeutics, Inc. is a biotechnology company developing biologics for the treatment of atopic dermatitis, COPD, and related inflammatory and immunology conditions. Founded in 2022 and based in Waltham, Massachusetts.
Symbol: APGE
Recent Price: $44.64
Industry: Biotechnology
CEO: Dr. Michael Thomas Henderson M.D.
Sector: Healthcare
Employees: 91
Address: 221 Crescent Street, Waltham, MA 02453
Phone: 650-394-5230
Last updated: 2024-12-31
89bio, Inc.
pegozafermin
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.
Symbol: ETNB
Recent Price: $7.87
Industry: Biotechnology
CEO: Mr. Rohan Palekar
Sector: Healthcare
Employees: 70
Address: 142 Sansome Street, San Francisco, CA 94104
Phone: 415 432 9270
Last updated: 2024-12-31
Fortress Biotech, Inc.
Pharmaceutical and Biotechnology Products
Fortress Biotech, Inc., is a biopharmaceutical company focused on developing and commercializing a range of dermatology products and late-stage product candidates for various medical conditions.
About | About | About | Leadership | Directors | About | About | Contact | Careers | Careers | Careers | About | About | About
Symbol: FBIO
Recent Price: $2.18
Industry: Biotechnology
CEO: Dr. Lindsay Allan Rosenwald
Sector: Healthcare
Employees: 186
Address: 1111 Kane Concourse, Bay Harbor Islands, FL 33154
Phone: 781 652 4500
Leadership
- Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer
- Michael S. Weiss, Executive Vice Chairman, Strategic Development
- David Jin, Chief Financial Officer and Head of Corporate Development
- George Avgerinos, Ph.D., Senior Vice President, Biologics Operations
- Samuel Berry, General Counsel and Corporate Secretary
- Jimmie Harvey, Jr., M.D., Director
- Malcolm Hoenlein, Director
- Dov Klein, Director
- J. Jay Lobell, Director
- Kevin L. Lorenz, J.D., Director
- Lucy Lu, M.D., Director
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Pliant Therapeutics, Inc.
PLN-74809
Pliant Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for the treatment of fibrosis and related diseases. Their lead product candidate, PLN-74809, is currently in Phase 2a trials.
Symbol: PLRX
Recent Price: $12.79
Industry: Biotechnology
CEO: Dr. Bernard Coulie M.B.A., M.D., Ph.D.
Sector: Healthcare
Employees: 166
Address: 260 Littlefield Avenue, South San Francisco, CA 94080
Phone: 650 481 6770
Last updated: 2024-12-31
Poseida Therapeutics, Inc.
P-PSMA-101
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company focusing on developing innovative CAR-T therapies for patients with high unmet medical needs, including treatments for prostate cancer, multiple myeloma, and various solid tumors.
Symbol: PSTX
Recent Price: $9.48
Industry: Biotechnology
CEO: Dr. Kristin Yarema Ph.D.
Sector: Healthcare
Employees: 337
Address: 9390 Towne Centre Drive, San Diego, CA 92121
Phone: 858 779 3100
Last updated: 2024-12-31
PTC Therapeutics, Inc.
Translarna, Emflaza, Tegsedi, Waylivra, Evrysdi
PTC Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for patients with rare disorders. The company offers a portfolio of products including treatments for Duchenne muscular dystrophy, rare diseases, and spinal muscular atrophy.
About | History | Leadership | About | Contact | Careers | Careers | Jobs | About | About | About | About
Symbol: PTCT
Recent Price: $45.77
Industry: Biotechnology
CEO: Dr. Matthew B. Klein F.A.C.S., M.D., M.S.
Sector: Healthcare
Employees: 988
Address: 100 Corporate Court, South Plainfield, NJ 07080
Phone: 908 222 7000
Leadership
- Matthew B. Klein, M.D., M.S., F.A.C.S., CEO, PTC Therapeutics, Inc.
- Neil Almstead, Ph.D., Chief Technical Operations Officer
- John Baird, Ph.D., Chief of Staff to the CEO
- Mark E. Boulding, Executive Vice President and Chief Legal Officer
- Lee Golden, M.D., Chief Medical Officer
- Pierre Gravier, Chief Financial Officer
- Mary Frances Harmon, Senior Vice President, Corporate and Patient Relations
- Linda Montella-Carter, Senior Vice President and Chief Information Officer
- Eric Pauwels, Chief Business Officer
- Hege Sollie-Zetlmayer, Chief Human Resources Officer
- Christine Utter, Senior Vice President, Chief Accounting Officer and Head of People Services
- Michael Schmertzler, Chairman
- William F. Bell, Jr., Managing Director and Head of Healthcare Services Practice, L.E.K. Consulting
- Allan Jacobson, Ph.D., University of Massachusetts Chan Medical School
- Stephanie S. Okey, M.S., Former SVP, Head of North America, Rare Disease – Genzyme
- Emma Reeve, Independent Board Director
- Mary Smith, The VENG Group
- David P. Southwell, Former CEO, TScan Therapeutics
- Glenn D. Steele, Jr., M.D., Ph.D., Chairman, GSteele Health Solutions
- Alethia Young, Chief Financial Officer, Bicycle Therapeutics
- Jerome B. Zeldis, M.D., Ph.D., Independent Board Director
Last updated: 2024-12-31
Protagenic Therapeutics, Inc.
PT00114
Protagenic Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing therapeutics for stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, aims to regulate stress response and restore healthy brain function.
Symbol: PTIX
Recent Price: $0.54
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 1
Address: 149 Fifth Avenue, New York, NY 10010
Phone: 212 994 8200
Last updated: 2024-12-31
RAPT Therapeutics, Inc.
RPT193, FLX475
RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule therapies targeting oncology and inflammatory diseases. Its leading drug candidates include RPT193 for inflammation and FLX475 for oncology.
About | About | About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About
Symbol: RAPT
Recent Price: $1.62
Industry: Biotechnology
CEO: Dr. Brian Russell Wong M.D., Ph.D.
Sector: Healthcare
Employees: 122
Address: 561 Eccles Avenue, South San Francisco, CA 94080
Phone: 650 489 9000
Last updated: 2024-12-31
Regulus Therapeutics Inc.
RG-012 and RGLS8429
Regulus Therapeutics Inc., based in San Diego, focuses on discovering and developing drugs targeting micro RNAs for treating various diseases.
Symbol: RGLS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Joseph P. Hagan M.B.A.
Sector: Healthcare
Employees: 30
Address: 4224 Campus Point Court, San Diego, CA 92121
Phone: 858 202 6300
Last updated: 2024-12-31
Rigel Pharmaceuticals, Inc.
Tavalisse
Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases.
Symbol: RIGL
Recent Price: $16.47
Industry: Biotechnology
CEO: Mr. Raul R. Rodriguez
Sector: Healthcare
Employees: 147
Address: 1180 Veterans Boulevard, South San Francisco, CA 94080
Phone: 650 624 1100
Last updated: 2024-12-31
TransCode Therapeutics, Inc.
TTX-MC138
Trans Code Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing drugs and diagnostics for treating metastatic disease. Their lead product, TTX-MC138, is aimed at metastatic cancer treatment, along with a range of other therapeutic platforms targeting cancer through innovative RNA- and CRISPR-based technologies.
Symbol: RNAZ
Recent Price: $3.76
Industry: Biotechnology
CEO: Mr. Thomas A. Fitzgerald M.B.A.
Sector: Healthcare
Employees: 10
Address: 6 Liberty Square, Boston, MA 02109
Phone: 857-837-3099
Last updated: 2024-12-31
Rezolute, Inc.
RZ358
Rezolute, Inc. is a clinical stage biopharmaceutical company focused on developing transformative therapies for metabolic diseases related to chronic glucose imbalance. Its lead product, RZ358, is aimed at treating congenital hyperinsulinism.
Symbol: RZLT
Recent Price: $4.89
Industry: Biotechnology
CEO: Mr. Nevan Charles Elam J.D.
Sector: Healthcare
Employees: 59
Address: 201 Redwood Shores Parkway, Redwood City, CA 94065
Phone: 650 206 4507
Last updated: 2024-12-31
Titan Pharmaceuticals, Inc.
Pro Neura
Titan Pharmaceuticals, Inc. is a pharmaceutical company developing therapeutics for chronic diseases utilizing the Pro Neura drug delivery platform. Its products include the Probuphine implant for opioid use disorder treatment, among other programs for chronic pruritus, opioid relapse prevention, HIV prevention, and contraception.
About | About | Leadership | Directors | About | Contact | Directors | Directors | Directors | Careers | About
Symbol: TTNP
Recent Price: $3.40
Industry: Biotechnology
CEO: Jennifer Kiernan
Sector: Healthcare
Employees: 4
Address: 400 Oyster Point Boulevard, South San Francisco, CA 94080-1958
Phone: 650 244 4990
Leadership
- Dato’ Seow Gim Shen, Chief Executive Officer and Chairman of the Board of Directors
- Avraham Ben-Tzvi, Founder
- Brynner Chiam, Vice President of Finance and Tax
- Firdauz Edmin Bin Mokhtar, Chief Executive Officer
- Francisco Osvaldo Flores García, Managing Partner
Last updated: 2024-12-31
Crinetics Pharmaceuticals, Inc.
Paltusotine
Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on discovering, developing, and commercializing therapeutics for rare endocrine diseases and related tumors. Their leading product candidate, Paltusotine, has completed phase III trials for acromegaly treatment.
About | About | About | Contact | Contact | About | About | Culture | Culture | Careers | Jobs | Benefits | Jobs | Careers | Careers | Careers | About | About | About | About | About | About | About | About | About | About | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Careers | Vision/Values | Careers | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Jobs | Careers | Culture | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About | About | About | Careers | Careers
Symbol: CRNX
Recent Price: $50.67
Industry: Biotechnology
CEO: Dr. R. Scott Struthers Ph.D.
Sector: Healthcare
Employees: 290
Address: Building No. 2, San Diego, CA 92121
Phone: 858 450 6464
Last updated: 2024-12-31
Terns Pharmaceuticals, Inc.
TERN-101, TERN-201, TERN-501, TERN-601
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.
About | Contact | Careers | Careers | Careers | About | About | Careers | Culture | About | Leadership | About
Symbol: TERN
Recent Price: $7.15
Industry: Biotechnology
CEO: Ms. Amy L. Burroughs M.B.A.
Sector: Healthcare
Employees: 66
Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404
Phone: 650 525 5535
Last updated: 2024-11-08